Equities research analysts at UBS AG assumed coverage on shares of Victrex plc (LON:VCT) in a note issued to investors on Monday, investing.thisismoney.co.uk reports. The brokerage set a “neutral” rating and a GBX 2,050 ($26.61) price target on the stock. UBS AG’s target price suggests a potential downside of 0.15% from the stock’s previous close.

Other research analysts have also recently issued reports about the stock. Peel Hunt reiterated an “add” rating and set a GBX 2,100 ($27.26) price objective on shares of Victrex plc in a report on Tuesday, July 25th. Liberum Capital reiterated a “buy” rating and set a GBX 2,240 ($29.08) price objective on shares of Victrex plc in a report on Friday, June 16th. Barclays PLC reiterated an “equal weight” rating and set a GBX 1,940 ($25.18) price objective (up from GBX 1,600 ($20.77)) on shares of Victrex plc in a report on Friday, April 28th. Deutsche Bank AG reiterated a “hold” rating and set a GBX 1,850 ($24.02) price objective on shares of Victrex plc in a report on Friday, June 30th. Finally, Berenberg Bank lifted their price objective on shares of Victrex plc from GBX 1,800 ($23.37) to GBX 2,000 ($25.96) and gave the company a “hold” rating in a report on Tuesday, May 16th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of GBX 1,980.91 ($25.72).

Shares of Victrex plc (LON:VCT) opened at 2046.00 on Monday. The firm’s market capitalization is GBX 1.75 billion. Victrex plc has a 52-week low of GBX 1,473.00 and a 52-week high of GBX 2,064.00. The company’s 50-day moving average price is GBX 1,947.81 and its 200-day moving average price is GBX 1,934.13.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was illegally copied and reposted in violation of United States & international trademark and copyright laws. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/08/21/victrex-plc-vct-now-covered-by-ubs-ag.html.

About Victrex plc

Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.

Analyst Recommendations for Victrex plc (LON:VCT)

Receive News & Ratings for Victrex plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex plc and related companies with MarketBeat.com's FREE daily email newsletter.